TrialAntimicrobial agents and chemotherapy2000

Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group.

V Joly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.